1. CMU Intellectual Repository

Browsing by Author Javier Lama

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)
1-Jun-2022Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapyClaudia Hawkins; Minhee Kang; Debika Bhattacharya; Gavin Cloherty; Mary Kuhns; Roy Matining; Chloe Thio; Wadzanai Samaneka; Lameck Chinula; Nyirenda Mulinda; Sharlaa Badal-Faesen; Patcharaphan Sugandhavesa; Javier Lama; Simani Gaseitsiwe; Vera Holzmayer; Mark Anderson; Robert Murphy; Marion Peters
1-Jul-2017High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender womenAlex Carballo-Diéguez; Ivan C. Balán; William Brown; Rebecca Giguere; Curtis Dolezal; Cheng Shiun Leu; Mark A. Marzinke; Craig W. Hendrix; Jeanna M. Piper; Barbra A. Richardson; Cynthia Grossman; Sherri Johnson; Kailazarid Gomez; Stephanie Horn; Ratiya Pamela Kunjara Na Ayudhya; Karen Patterson; Cindy Jacobson; Linda Gail Bekker; Suwat Chariyalertsak; Anupong Chitwarakorn; Pedro Gonzales; Timothy H. Holtz; Albert Liu; Kenneth H. Mayer; Carmen Zorrilla; Javier Lama; Ian McGowan; Ross D. Cranston
1-Dec-2015HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trialMadeline B. Deutsch; David V. Glidden; Jae Sevelius; Joanne Keatley; Vanessa McMahan; Juan Guanira; Esper G. Kallas; Suwat Chariyalertsak; Robert M. Grant; Javier Lama; Mauro Schechter; Valdilea Veloso; Linda Gail Bekker; Kenneth Mayer; Susan Buchbinder; Orlando Montoya; Martin Casapia; Sybil Hosek; Albert Liu; Rivet Amico; Kimberly Koester; Kathleen Mulligan
1-Mar-2021Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB preventionA. T. Podany; J. Leon-Cruz; J. Hakim; K. Supparatpinyo; A. Omoz-Oarhe; D. Langat; N. Mwelase; C. Kanyama; A. Gupta; C. A. Benson; R. E. Chaisson; S. Swindells; C. V. Fletcher; Peter Kim; Daniel Johnson; Laura Moran; Janet Andersen; Yajing Bao; Shirley Wu; Christina Blanchard-Horan; Ann Walawander; Katherine Shin; Ruth Ebiasah; David Holland; Marc Antoine Jeanjuste; Eric Nuermberger; Sandy Pillay; Ian Sanne; Janet Nicotera; David Shugarts; Amina Shali; Jimi Tutko; Brigitte Demers; Marilyn Maroni; Jorge L. Sanchez; David Iglesias; Javier Lama; Mitch Matoga; Guilherme Do Amaral Calvet; Ronald Kibet Tonui; Taolo Modise; Margaret Kasaro; Kogieleum Naidoo; Deelip Kadam; William Burman
1-Jan-2016The safety of tenofovir-emtricitabine for HIV pre-exposure prophylaxis (PrEP) in individuals with active hepatitis BMarc M. Solomon; Mauro Schechter; Albert Y. Liu; Vanessa M. McManhan; Juan V. Guanira; Robert J. Hance; Suwat Chariyalertsak; Kenneth H. Mayer; Robert M. Grant; Linda Gail Bekker; Susan Buchbinder; Martin Casapia; Esper Kallas; Javier Lama; Orlando Montoya; Valdiléa Veloso
1-Oct-2014Syphilis predicts HIV incidence among men and transgender women who have sex with men in a preexposure prophylaxis trialMarc M. Solomon; Kenneth H. Mayer; David V. Glidden; Albert Y. Liu; Vanessa M. McMahan; Juan V. Guanira; Suwat Chariyalertsak; Telmo Fernandez; Robert M. Grant; Linda Gail Bekker; Susan Buchbinder; Martin Casapia; Esper Kallas; Javier Lama; Orlando Montoya; Mauro Schechter; Valdiléa Veloso
Showing results 1 to 6 of 6